Hanmi Pharmaceutical Sets Third — Quarter Earnings Release
Hanmi Pharmaceutical plans to release preliminary third-quarter earnings for July 1-Sept. 30, 2026, on Oct. 27, 2026. Results materials will be posted on its Investor Relations website following the Oct. 27, 2026, disclosure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanmi Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016800700), on October 16, 2026, and is solely responsible for the information contained therein. (C)
Hanmi Pharmaceutical plans to release preliminary third-quarter earnings for July 1-Sept. 30, 2026, on Oct. 27, 2026. Results materials will be posted on its Investor Relations website following the Oct.
27, 2026, disclosure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanmi Pharmaceutical Co.
Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016800700), on October 16, 2026, and is solely responsible for the information contained therein. (C)